Anaphylactic-like reaction to suxamethonium.

Area of Science:

• Anesthesiology
• Clinical Immunology
• Pharmacology

Background:

• Anaphylactic reactions during anesthesia induction pose significant risks.
• Suxamethonium is a common neuromuscular blocking agent used in anesthesia.
• Identifying causative agents and cross-reactivity is crucial for patient safety.

Observation:

• A young woman presented with an anaphylactic-type reaction upon induction of anesthesia.
• The reaction was attributed to suxamethonium, a drug with no prior exposure.
• Patient's leucocytes showed in vitro reactions to suxamethonium and related compounds.

Findings:

• In vitro testing confirmed suxamethonium as the allergen.
• Pharmacologically and chemically related agents also triggered leucocyte reactions.
• Unrelated neuromuscular blocking drugs did not elicit a reaction, indicating potential safety.
• Family members, including a brother, showed varying degrees of leucocyte reactivity.
• Skin testing corroborated in vitro histamine release findings.

Implications:

• This case highlights the potential for unexpected anaphylaxis to suxamethonium.
• In vitro testing can identify specific drug allergies and cross-reactivity patterns.
• Findings suggest that 'unrelated' neuromuscular blocking agents may be safely used in susceptible patients.
• Understanding familial reactivity may inform risk assessment in relatives.
• Provides crucial data for anesthetic drug selection in patients with suspected suxamethonium allergy.